Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3013 to 3016 of 3016 entries
Sorted by: Best Match Show Resources per page
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.

Dermatitis : contact, atopic, occupational, drug

Simpson EL, Wollenberg A, Bissonnette R, Silverberg JI, Papacharalambous J, Zhu L, Zhang W, Beebe JS, Vincent M, Peeva E, Bushmakin AG, Cappelleri JC, Chen L, Sikirica V, Xenakis J.
PMID: 33795561
Dermatitis. 2021 Oct 01;32(1):S53-S61. doi: 10.1097/DER.0000000000000725.

BACKGROUND: Moderate-to-severe atopic dermatitis (AD) is inadequately controlled with current treatments for many patients. Abrocitinib is an oral Janus kinase 1 selective inhibitor under investigation for the treatment of AD.OBJECTIVE: The aim of the study was to evaluate patient-reported...

Cite
Simpson EL, Wollenberg A, Bissonnette R, et al. Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib. Dermatitis. 2021;32(1):S53-S61doi: 10.1097/DER.0000000000000725.
Simpson, E. L., Wollenberg, A., Bissonnette, R., Silverberg, J. I., Papacharalambous, J., Zhu, L., Zhang, W., Beebe, J. S., Vincent, M., Peeva, E., Bushmakin, A. G., Cappelleri, J. C., Chen, L., Sikirica, V., & Xenakis, J. (2021). Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib. Dermatitis : contact, atopic, occupational, drug, 32(1), S53-S61. https://doi.org/10.1097/DER.0000000000000725
Simpson, Eric L, et al. "Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib." Dermatitis : contact, atopic, occupational, drug vol. 32,1 (2021): S53-S61. doi: https://doi.org/10.1097/DER.0000000000000725
Simpson EL, Wollenberg A, Bissonnette R, Silverberg JI, Papacharalambous J, Zhu L, Zhang W, Beebe JS, Vincent M, Peeva E, Bushmakin AG, Cappelleri JC, Chen L, Sikirica V, Xenakis J. Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib. Dermatitis. 2021 Oct 01;32(1):S53-S61. doi: 10.1097/DER.0000000000000725. PMID: 33795561.
Copy Download .nbib Format: NLM
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma.

Translational lung cancer research

Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS.
PMID: 34430361
Transl Lung Cancer Res. 2021 Jul;10(7):3236-3250. doi: 10.21037/tlcr-21-543.

BACKGROUND: The concordance between mutations detected from plasma and tissue is critical for treatment choices of patients with advanced lung adenocarcinoma.METHODS: We prospectively analyzed the association of the serum tumor markers with the concordance between blood and tissue genomic...

Cite
Jiao XD, Ding LR, Zhang CT, et al. Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Transl Lung Cancer Res. 2021;10(7):3236-3250doi: 10.21037/tlcr-21-543.
Jiao, X. D., Ding, L. R., Zhang, C. T., Qin, B. D., Liu, K., Jiang, L. P., Wang, X., Lv, L. T., Ding, H., Li, D. M., Yang, H., Chen, X. Q., Zhu, W. Y., Wu, Y., Ling, Y., He, X., Liu, J., Shao, L., Wang, H. Z., Chen, Y., Zheng, J. J., Inui, N., & Zang, Y. S. (2021). Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Translational lung cancer research, 10(7), 3236-3250. https://doi.org/10.21037/tlcr-21-543
Jiao, Xiao-Dong, et al. "Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma." Translational lung cancer research vol. 10,7 (2021): 3236-3250. doi: https://doi.org/10.21037/tlcr-21-543
Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS. Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Transl Lung Cancer Res. 2021 Jul;10(7):3236-3250. doi: 10.21037/tlcr-21-543. PMID: 34430361; PMCID: PMC8350084.
Copy Download .nbib Format: NLM
Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review.

Frontiers in genetics

Yang R, Lu Y, Yang C, Wu X, Feng J, Zhu L, Shu Q, Jiang P.
PMID: 34456971
Front Genet. 2021 Aug 12;12:694683. doi: 10.3389/fgene.2021.694683. eCollection 2021.

Congenital hypothyroidism (CH) is the most common neonatal metabolic disorder. Although it has been understood to be a monogenic disease, some CH patients are reported to carry two or more variants at different genes. Here, ten permanent congenital hypothyroidism...

Cite
Yang R, Lu Y, Yang C, et al. Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review. Front Genet. 2021;12:694683doi: 10.3389/fgene.2021.694683.
Yang, R., Lu, Y., Yang, C., Wu, X., Feng, J., Zhu, L., Shu, Q., & Jiang, P. (2021). Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review. Frontiers in genetics, 12694683. https://doi.org/10.3389/fgene.2021.694683
Yang, Rulai, et al. "Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review." Frontiers in genetics vol. 12 (2021): 694683. doi: https://doi.org/10.3389/fgene.2021.694683
Yang R, Lu Y, Yang C, Wu X, Feng J, Zhu L, Shu Q, Jiang P. Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review. Front Genet. 2021 Aug 12;12:694683. doi: 10.3389/fgene.2021.694683. eCollection 2021. PMID: 34456971; PMCID: PMC8397485.
Copy Download .nbib Format: NLM
[Technical recommendation for pragmatic randomized controlled trial of heat-sensitive moxibustion in community (Ⅰ): randomization with consideration of patient preference].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Zhou X, Wen ZH, Li L, Liu JP, Gu YH, Guo XF, Liao X, Zhu WF, Li SQ, Sun X.
PMID: 35025163
Zhongguo Zhen Jiu. 2022 Jan 12;42(1):85-90. doi: 10.13703/j.0255-2930.20210512-k0004.

Heat-sensitive moxibustion is the appropriate technique of the external treatment in traditional Chinese medicine and it is widely used in community because of its "easy learning, simple operation and clear curative effect". Pragmatic randomized controlled trial is a main...

Cite
Zhou X, Wen ZH, Li L, et al. [Technical recommendation for pragmatic randomized controlled trial of heat-sensitive moxibustion in community (Ⅰ): randomization with consideration of patient preference]. Zhongguo Zhen Jiu. 2022;42(1):85-90doi: 10.13703/j.0255-2930.20210512-k0004.
Zhou, X., Wen, Z. H., Li, L., Liu, J. P., Gu, Y. H., Guo, X. F., Liao, X., Zhu, W. F., Li, S. Q., & Sun, X. (2022). [Technical recommendation for pragmatic randomized controlled trial of heat-sensitive moxibustion in community (Ⅰ): randomization with consideration of patient preference]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 42(1), 85-90. https://doi.org/10.13703/j.0255-2930.20210512-k0004
Zhou, Xu, et al. "[Technical recommendation for pragmatic randomized controlled trial of heat-sensitive moxibustion in community (Ⅰ): randomization with consideration of patient preference]." Zhongguo zhen jiu = Chinese acupuncture & moxibustion vol. 42,1 (2022): 85-90. doi: https://doi.org/10.13703/j.0255-2930.20210512-k0004
Zhou X, Wen ZH, Li L, Liu JP, Gu YH, Guo XF, Liao X, Zhu WF, Li SQ, Sun X. [Technical recommendation for pragmatic randomized controlled trial of heat-sensitive moxibustion in community (Ⅰ): randomization with consideration of patient preference]. Zhongguo Zhen Jiu. 2022 Jan 12;42(1):85-90. doi: 10.13703/j.0255-2930.20210512-k0004. Chinese. PMID: 35025163.
Copy Download .nbib Format: NLM
Showing 3013 to 3016 of 3016 entries